FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
Comments Off on FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
June 4, 2026
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
The First Cannabis Drug to Earn FDA Breakthrough Therapy Status for Pain`
Comments Off on The First Cannabis Drug to Earn FDA Breakthrough Therapy Status for Pain`
May 24, 2026
The FDA has granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract, after two Phase 3 RCTs showed significant pain reduction in patients with chronic low back pain. VER-01 outperformed opioids on both pain relief and…